ALL HYPOTHESES
Repurposing candidates for cabozantinib
Inflammatory bowel disease 1
| Mediator | Outcome | Score | Tier | Lit. status | Trial | |
|---|---|---|---|---|---|---|
| AXL | IBD | 0.208 | Mid | novel signal | active |
Rheumatoid arthritis 2
| Mediator | Outcome | Score | Tier | Lit. status | Trial | |
|---|---|---|---|---|---|---|
| AXL | low disease activity | 0.208 | Mid | novel signal | none | |
| AXL | pro-inflammatory gene expression | 0.208 | Mid | novel signal | none |